Applied Molecular Transport Completes Enrollment Of Phase 2 LOMBARD Monotherapy Trial Of Oral AMT-101 In Patients With Moderate-to-Severe Ulcerative Colitis
Applied Molecular Transport Inc. (NASDAQ:AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the company has completed enrollment of the Phase 2 LOMBARD trial for AMT-101 in 105 patients with
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 132 stocks hit new 52-week lows.
Jefferies Downgrades Applied Molecular to Hold
Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
Dow Jumps More Than 100 Points Following Release Of Fed Minutes
U.S. stocks traded higher toward the end of trading, following the release of minutes from the recent Federal Reserve meeting, which suggest inflation remains the central bank's top priority. The country's central bank reiterated its prior intentions to do whatever it takes to bring inflation down.